ARM
AMRI

Adirondack Research & Management’s Albany Molecular Research Inc AMRI Stock Holding History

Adirondack Research & Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-55,583
Closed -$660K – 98
2013
Q2 		$660K Buy
+55,583
New +$602K 0.49% 70

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adirondack Research & Management's AMRI Position: Q3 2013 in Review

Adirondack Research & Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2013, closing a stake of 55,583 shares — an estimated $660K sold.

Adirondack Research & Management first reported a position in AMRI in Q2 2013 and held it in 1 quarter. The position peaked at $660K in Q2 2013. 103 funds tracked by Wall St. Rank hold AMRI as of Q3 2013.

  • Adirondack Research & Management reported no remaining Albany Molecular Research Inc position as of Q3 2013 after selling out during the quarter.
  • Adirondack Research & Management sold 55,583 Albany Molecular Research Inc shares in Q3 2013, an estimated $660K.
  • Adirondack Research & Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 1 quarter.
  • Adirondack Research & Management's Albany Molecular Research Inc position peaked at $660K in Q2 2013.
  • 103 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2013.

Based on Adirondack Research & Management's 13F filing for Q3 2013, filed 6 Nov 2013.